Type 2 diabetes is a serious and common chronic disease resulting from a complex
inheritance-environment interaction along with other risk factors such as obesity and …

Background: The clinical goal in the treatment of diabetes is to achieve good glycemic
control. Tight glycemic control achieved with intensive glucose lowering treatment reduces …

OBJECTIVE:: This study evaluated the impact on adherence, hypoglycemic events, resource
utilization, and the associated health care costs of converting from administration of insulin …

Hypoglycemia is a common, potentially avoidable consequence of diabetes treatment and is
a major barrier to initiating or intensifying antihyperglycemic therapy in efforts to achieve …

AIMS: To quantify patient-reported rates of hypoglycemia and its association with health-
related quality of life (HRQL), treatment satisfaction, and healthcare resource utilization …

OBJECTIVE Continuous glucose monitoring (CGM) has been found to improve glucose
control in type 1 diabetic patients. We estimated the cost-effectiveness of CGM versus …

Type 2 diabetes mellitus (T2DM) is a chronic illness that requires clinical recognition and
treatment of the dual pathophysiologic entities of altered glycemic control and insulin …

The therapeutic goal in insulin-treated diabetic patients is to maintain on the long-term a
tight glucose control (HbA1c< 6, 5-7% or less) through an insulin regimen which “mimic” the …

Hypoglycemia is a significant problem in elderly adults with diabetes mellitus. Elderly
individuals with diabetes mellitus are at greater risk than younger adults for hypoglycemic …

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C
level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic …